Immunoglobulin Gene Rearrangement in Plasma Cell Dyscrasias: Detection of Small Clonal Cell Populations in Peripheral Blood and Bone Marrow

References

• Cleary M. L., Chao J., Warnke R., Sklar J. lmmunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc. Nalt. Acad. Sci. USA 1984; 81: 593–7
   PubMed Web of Science ®Google Scholar
• Anderson K. C., Barut B. A., Ritz J., Freedman A. S., Takvonan T., Rabinowe S. N., Soiffer R., Heflin L., Coral F., Dear K., Mauch P., Nadler L. M. Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma. Blood 1991; 77: 712–20
   PubMed Web of Science ®Google Scholar
• Kubagawa H., Vogler L. B., Capra J. D., Conrad M. E., Lawton A. R., Cooper M. D. Studies on the clonal origin of multiple myeloma. J. Exp. Med. 1979; 150: 792–807
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Bergui L., Tesio L., Pizzolo G., Malavasi F., Chilosi M., Campana D., van Camp B., Janossy G. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J. Clin. Invest. 1985; 76: 1243–51
   PubMed Web of Science ®Google Scholar
• Grogan T. M., Durie B. G. M., Lomen C., Spier C., Wirt D. P., Nagle R., Wilson G. S., Richter L., Vela E., Maxey V., McDaniel K., Rangel C. Delineation of a novel pre-B cell component in plasma cell myeloma: Immunochemical, immuno-phenotypic, genotypic, cytologic, cell culture, and kinetic features. Blood 1987; 70: 93242
   Google Scholar
• Epstein J., Barlogie B., Katzmann J., Alexanian J. Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood 1988; 71: 861–5
   PubMed Web of Science ®Google Scholar
• Warburton P., Joshua D. E., Gibson J., Brown R. D. CDlO-(CALLA) positive lymphocytes in myeloma: evidence that they are a malignant precursor population and are of germinal Centre origin. Leukemia and Lymphoma 1989; 1: 11–20
   PubMedGoogle Scholar
• Mellstedt H., Hammarstrom S., Holm G. Monoclonal lymphocyte population in human plasma cell myeloma. Clin. Exp. Immunol. 1974; 17: 371–84
   PubMed Web of Science ®Google Scholar
• Warner T. F. C. S., Krueger R. G. Circulating lymphocytes and the spread of myeloma. Lancer 1978; 1174–6
   PubMed Web of Science ®Google Scholar
• Gobbi M., Caligaris-Cappio F., Campana D., Tazzari P. L., Bergui L., Cavo M., Tura S. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen. Clin. Exp. Immunol. 1984; 58: 625–30
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Mant M. J., Ruether B. A., Belch A. Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients. J. Clin. Invest. 1984; 74: 1301–6
   PubMed Web of Science ®Google Scholar
• King M. A., Nelson D. S. Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic and functional studies of cells from blood and bone marrow. Blood 1989; 73: 1925–35
   PubMed Web of Science ®Google Scholar
• King M. A., Wells J. V. Cell bound immunoglobulin on peripheral blood mononuclear cells of patients with myeloma. Clin. Exp. Immunol. 1981; 45: 552–6
   PubMed Web of Science ®Google Scholar
• Berenson J., Wong R., Kim K., Brown N., Lichtenstein A. Evidence for peripheral blood B lymphocyte and not T lymphocyte involvement in multiple myeloma. Blood 1987; 70: 1550–3
   PubMed Web of Science ®Google Scholar
• Chiu E. K. W., Ganeshaguru K., Hoffbrand A. V., Mehta A. B. Circulating monoclonal B-lymphocytes in multiple myeloma. Brit. J. Haematol 1989; 72: 28–31
   PubMed Web of Science ®Google Scholar
• Van Riet I., Heirman C., Lacor P., De Waele M., Thielemans K., van Camp B. Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies. Brit. J. Haematol 1989; 73: 289–95
   PubMed Web of Science ®Google Scholar
• Oster W., Lindemann A., Mertelsmann R., Herrmann F. Minimal peripheral blood cells carrying clonal markers of B cell disorders: Evidence for monoclonality of circulating lymphocytes in patients with multiple myeloma. Int. J. Cell Cloning 1989; 7: 111–9
   PubMedGoogle Scholar
• Cassel A., Leibovitz N., Hornstein L., Quitt M., Aghai E. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients. Exp. Haematol 1990; 18: 1171–3
   PubMed Web of Science ®Google Scholar
• Bagg A., Becker P., Bezwoda W., van Rensburg L., Mendelow B. Circulating monotypic B-cells in multiple myeloma: Association with lambda paraproteins. Brit. J. Haematol 1989; 11: 167–72
   Web of Science ®Google Scholar
• Clofent G., Klein B., Commes T., Ghanem N., Lefranc M. P., Bataille R. No detectable malignant B cells in the peripheral blood of patients with multiple myeloma. Brit. J. Haematol 1989; 71: 357–61
   PubMed Web of Science ®Google Scholar
• Baldini L., Cro L., Delia D., Chiorboli O., Neri A., Maiolo A. T. Analysis of tumor-specific immunoglobulin gene rearrangement in peripheral blood B-cells of multiple myeloma patients. Am. J. Hematol 1991; 37: 1–5
   PubMed Web of Science ®Google Scholar
• Durie B. G. M., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 1975; 36: 842–54
   PubMed Web of Science ®Google Scholar
• Lichtman M. A. Essential and secondary monoclonal gammopathies. Hematology, W. J. Williams, E. Beutler, A. J. Erslev, M. A. Lichtman. McGraw-Hill Inc, New York 1990; 1109–14
   Google Scholar
• Sambrook J., Fritsch E. F., Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1989
   Google Scholar
• Griinewald K., Lyons J., Hansen-Hagge T. E., Janssen J. W. G., Feichtinger H., Bartram C. R. Molecular genetic analysis of DNA obtained from fixed, air dried or paraffin embedded sources. Ann. Hematol 1991; 62: 108–14
   PubMed Web of Science ®Google Scholar
• Bakhshi A., Minowada J., Arnold A., Cossman J., Jensen J. P., Whang-Peng J., Waldmann T. A., Korsmeyer S. J. Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. N. Engl J. Med. 1983; 309: 826–31
   PubMed Web of Science ®Google Scholar
• Feinberg A. B., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 1984; 137: 266–7
   PubMed Web of Science ®Google Scholar
• Boehm T., Baer R., Lavenir I., Forster A., Waters J. J., Nacheva E., Rabbitts T. H. The mechanism of chromosomal translocation t(ll;14) involving the T-cell receptor C<5 on human chromosome 14qll and a transcribed region of chromosome llpl5. EMBO J 1988; 7: 385–94
   PubMed Web of Science ®Google Scholar
• Selvanayagam P., Blick M., Narni F., van Tuinen P., Ledbetter D. H., Alexanian R., Saunders G. F., Barlogie B. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. Blood 1988; 71: 30–5
   PubMed Web of Science ®Google Scholar
• Zaccaria A., Tassinari A., Saglio G., Guerrasio A., Tura S. Immunoglobulin gene rearrangements in multiple myeloma. Brit. J. Haematol 1989; 73: 425
   PubMed Web of Science ®Google Scholar
• Humphries J. E., Dressman H. K., Williams M. E. Immunoglobulin gene rearrangement in multiple myeloma: limitations of Southern blot analysis. Hum. Pathol 1991; 22: 966–71
   PubMed Web of Science ®Google Scholar
• Fey M. F., Pilkington S. P., Summers C., Wainscoat J. S. Molecular diagnosis of haematological disorders using DNA from stored bone marrow slides. Brit. J. Haematol 1987; 67: 489–92
   PubMed Web of Science ®Google Scholar
• Bartl R., Frisch B., Fateh-Moghadam A., Kettner G., Jaeger K., Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am. J. Clin. Pathol 1987; 87: 342–55
   PubMed Web of Science ®Google Scholar
• Berenson J. R., Lichtenstein A. K. Clonal rearrangement of immunoglobulin genes in the peripheral blood of multiple myeloma patients. Brit. J. Haematol 1989; 73: 425–7
   PubMed Web of Science ®Google Scholar
• Ruiz-Argiielles G. J., Katzmann J. A., Greipp P. R., Gonchoroft N. J., Garton J. P., Kyle R. A. Multiple myeloma: circulating lymphocytes that express plasma cell antigens. Blood 1984; 64: 352–6
   PubMed Web of Science ®Google Scholar
• Omede P., Boccadoro M., Gallone G., Frieri R., Battaglio S., Redoglia V., Pileri A. Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as indicators of poor survival. Blood 1990; 76: 1375–9
   PubMed Web of Science ®Google Scholar
• Clofent G., Klein B., Commes T., Vincent C., Ghanem N., Lenoir G., Lefranc M. P., Bataille R. Limiting dilution cloning of B cells from patients with multiple myeloma: emergence of non-malignant B-cell lines. Int. J. Cancer 1989; 43: 578–86
   PubMed Web of Science ®Google Scholar
• Wright J. J., Poplack D. G., Bakhshi A., Reaman G., Cole D., Jensen J. P., Korsmeyer S. J. Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia. J. Clin. Oncol 1987; 5: 735–11
   PubMed Web of Science ®Google Scholar
• Kyle R. A. “Benign” monoclonal gammopathy. A misnomer?. Am. J. Med. 1984; 251: 1849–54
   PubMed Web of Science ®Google Scholar
• Radl J. Age-related monoclonal gammopathies: clinical lessons from the aging C56BL mouse. Immunol Today 1990; 11: 234–6
   PubMedGoogle Scholar
• Morell A., Maurer W., Skavril F., Barandun S. Differentiation between benign and malignant monoclonal gammopathies by discriminant analysis on serum and bone marrow parameters. Acta Haematol-Basel 1978; 60: 129–36
   PubMed Web of Science ®Google Scholar
• Greipp P. R., Kyle R. A. Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smouldering multiple myeloma. Blood 1983; 62: 166–71
   PubMed Web of Science ®Google Scholar